Last reviewed · How we verify

LTOT 24 h/day — Competitive Intelligence Brief

LTOT 24 h/day (LTOT 24 h/day) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory/Pulmonary.

marketed Respiratory/Pulmonary Small molecule Live · refreshed every 30 min

Target snapshot

LTOT 24 h/day (LTOT 24 h/day) — Skane University Hospital. LTOT 24 h/day delivers supplemental oxygen continuously throughout the day and night to maintain adequate blood oxygen levels in patients with chronic hypoxemia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LTOT 24 h/day TARGET LTOT 24 h/day Skane University Hospital marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LTOT 24 h/day — Competitive Intelligence Brief. https://druglandscape.com/ci/ltot-24-h-day. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: